Link to the University of Pittsburgh Homepage
Link to the University Library System Homepage Link to the Contact Us Form

Phase III, randomized, open-label study of durvalumab (MEDI4736) monotherapy, or durvalumab + tremelimumab, versus standard of care (SoC), in recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): eagle

Ferris, Robert L and Even, Caroline and Haddad, Robert and Tahara, Makoto and Goswami, Trishna and Franks, April and Emeribe, Ugochi and Jarkowski, Anthony and Melillo, Giovanni and Licitra, Lisa (2015) Phase III, randomized, open-label study of durvalumab (MEDI4736) monotherapy, or durvalumab + tremelimumab, versus standard of care (SoC), in recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): eagle. Journal for ImmunoTherapy of Cancer, 3 (Suppl ). P150 - P150. ISSN 2051-1426

[img]
Preview
PDF
Published Version
Available under License : See the attached license file.

Download (393kB) | Preview
[img] Plain Text (licence)
Available under License : See the attached license file.

Download (1kB)

Share

Citation/Export:
Social Networking:
Share |

Details

Item Type: Article
Status: Published
Creators/Authors:
CreatorsEmailPitt UsernameORCID
Ferris, Robert Lrlf1@pitt.eduRLF1
Even, Caroline
Haddad, Robert
Tahara, Makoto
Goswami, Trishna
Franks, April
Emeribe, Ugochi
Jarkowski, Anthony
Melillo, Giovanni
Licitra, Lisa
Centers: Other Centers, Institutes, or Units > Pittsburgh Cancer Institute
Date: 2015
Date Type: Publication
Journal or Publication Title: Journal for ImmunoTherapy of Cancer
Volume: 3
Number: Suppl
Page Range: P150 - P150
DOI or Unique Handle: 10.1186/2051-1426-3-s2-p150
Schools and Programs: School of Medicine > Immunology
School of Medicine > Otolaryngology
Refereed: Yes
ISSN: 2051-1426
Date Deposited: 09 Aug 2016 20:12
Last Modified: 02 Jul 2019 13:55
URI: http://d-scholarship.pitt.edu/id/eprint/29049

Metrics

Monthly Views for the past 3 years

Plum Analytics

Altmetric.com


Actions (login required)

View Item View Item